Abstract:Background: Increasing attention is being given to assessing treatment effect heterogeneity among individuals belonging to qualitatively different latent subgroups. Inference routinely proceeds by first partitioning the individuals into subgroups, then estimating the subgroup-specific average treatment effects. However, because the subgroups are only latently associated with the observed variables, the actual individual subgroup memberships are rarely known with certainty in practice and thus have to be imputed. Ignoring the uncertainty in the imputed memberships precludes misclassification errors, potentially leading to biased results and incorrect conclusions. Methods: We propose a strategy for assessing the sensitivity of inference to classification uncertainty when using such classify-analyze approaches for subgroup effect analyses. We exploit each individual's typically nonzero predictive or posterior subgroup membership probabilities to gauge the stability of the resultant subgroup-specific average causal effects estimates over different, carefully selected subsets of the individuals. Because the membership probabilities are subject to sampling variability, we propose Monte Carlo confidence intervals that explicitly acknowledge the imprecision in the estimated subgroup memberships via perturbations using a parametric bootstrap. The proposal is widely applicable and avoids stringent causal or structural assumptions that existing bias-adjustment or bias-correction methods rely on. Results: Using two different publicly available real-world datasets, we illustrate how the proposed strategy supplements existing latent subgroup effect analyses to shed light on the potential impact of classification uncertainty on inference. First, individuals are partitioned into latent subgroups based on their medical and health history. Then within each fixed latent subgroup, the average treatment effect is assessed using an augmented inverse propensity score weighted estimator. Finally, utilizing the proposed sensitivity analysis reveals different subgroup-specific effects that are mostly insensitive to potential misclassification. Conclusions: Our proposed sensitivity analysis is straightforward to implement, provides both graphical and numerical summaries, and readily permits assessing the sensitivity of any machine learning-based causal effect estimator to classification uncertainty. We recommend making such sensitivity analyses more routine in latent subgroup effect analyses.

Evaluating the impact of treating the optimal subgroup

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Selecting optimal subgroups for treatment using many covariates

Detecting critical treatment effect bias in small subgroups

Identifying treatment response subgroups in observational time-to-event data

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

Optimal subgroup selection

Minimax optimal subgroup identification

Testing for a treatment effect in a selected subgroup

Machine learning for subgroup discovery under treatment effect

Estimating the treatment effect in a subgroup defined by an early post-baseline biomarker measurement in randomized clinical trials with time-to-event endpoint

Treatment Effect Quantiles in Stratified Randomized Experiments and Matched Observational Studies

A Sparse Random Projection-Based Test for Overall Qualitative Treatment Effects

Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Estimating subgroup effects in generalizability and transportability analyses

Defining and Estimating Intervention Effects for Groups that will Develop an Auxiliary Outcome

Are causal effect estimations enough for optimal recommendations under multitreatment scenarios?

A comparison of methods for model selection when estimating individual treatment effects

Evaluating sensitivity to classification uncertainty in latent subgroup effect analyses

Optimal Statistical Inference for Individualized Treatment Effects in High-dimensional Models